2016 Competition Pharmaceutical products Sales 
PharmaKinnex
AUGUST 23, 2022
The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. – Inefficient & Expensive Sales Strategies. PharmaKinnex has spent more than 18 years helping companies adopt new strategies, increase profitability, and expand their product reach. August 23, 2022.
European Pharmaceutical Review
JUNE 24, 2022
This means numerous key aspects of how pharmaceuticals are regulated in the EU could be affected, from costing and reimbursement to intellectual property rights, incentives and more. Stakeholders in the EU often use the risk-adjusted Net Present Value (rNPV) investment model to determine whether to invest in a pharmaceutical product.
Expert insights. Personalized for you.
52 
Let's personalize your content